STERIS plc (STE) vs United Therapeutics Corporation (UTHR)
A side-by-side comparison of STERIS plc and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
STE
STERIS plc
$208.77HealthcareDelayed quote: Sep 24, 2026, 4:00 PM EDT
UTHR
United Therapeutics Corporation
$472.21HealthcareDelayed quote: Sep 24, 2026, 4:00 PM EDT
Total return — STE vs UTHR
growth of $100 · dividends reinvested · last 10ySTE +252.8% (+13.4%/yr)UTHR +312.8% (+15.2%/yr)UTHR compounded faster over this window
STE UTHR
STE vs UTHR: by the numbers
- •STE is the larger company ($20.35B vs $20.04B market cap).
- •UTHR trades at the lower trailing earnings multiple (16.92 vs 25.52 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (41.56% vs 13.33% net margin).
- •UTHR grew revenue faster over the past five years (14.68% vs 12.13% CAGR).
- •STE pays a dividend (1.20% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | STE | UTHR |
|---|---|---|
| P/E ratio | 25.52 | 16.92 |
| Forward P/E | 18.63 | 18.06 |
| P/S ratio | 3.37 | 6.35 |
| P/B ratio | 2.82 | 3.13 |
| EV / EBITDA | 12.08 | 12.20 |
| FCF yield | 4.55% | 5.45% |
Profitability
| Metric | STE | UTHR |
|---|---|---|
| Gross margin | 44.43% | 86.14% |
| Operating margin | 18.91% | 44.49% |
| Net margin | 13.33% | 41.56% |
| ROE | 11.17% | 20.48% |
| ROIC | 8.74% | 17.69% |
Dividends
| Metric | STE | UTHR |
|---|---|---|
| Dividend yield | 1.20% | N/A |
| Payout ratio | 30.81% | N/A |
Growth (annualized)
| Metric | STE | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | 12.13% | 14.68% |
| EPS CAGR (5Y) | 11.22% | 20.93% |
| FCF CAGR (5Y) | 16.89% | 14.31% |
| Total return CAGR (5Y) | 1.08% | 19.17% |
Frequently asked
- Which has the lower trailing P/E, STE or UTHR?
- UTHR has the lower trailing P/E: STE trades at 25.52 and UTHR at 16.92. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, STE or UTHR?
- Over the past five years, UTHR grew revenue faster — STE at a 12.13% CAGR versus UTHR at 14.68%.
- Does STE or UTHR pay a bigger dividend?
- STE pays a dividend (1.20% yield), while UTHR has no payments in the available dividend history.
- Is STE or UTHR more profitable?
- UTHR runs the higher net margin — STE at 13.33% versus UTHR at 41.56%.
- How have STE and UTHR total returns compared?
- Over the past 10 years, STE delivered 12.75% and UTHR delivered 15.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
STERIS P/E ratioUnited Therapeutics P/E ratioSTERIS dividend yieldSTERIS ROEUnited Therapeutics ROESTERIS operating marginUnited Therapeutics operating marginSTERIS revenue growthUnited Therapeutics revenue growthSTERIS free cash flowUnited Therapeutics free cash flow
STERIS & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.